Sanofi-Pasteur Archives -

Sanofi snaps up acne vaccine developer Origimm Bio

Phil Taylor Acne, dermatology, M&A, Origimm Biotechnology, Sanofi, Sanofi-Pasteur, vaccine 0 Comment

Sanofi has added to its vaccine pipeline with an agreement to acquire Austria’s Origimm Biotechnology and its vaccine-based

Sanofi snaps up acne vaccine developer Origimm Bio

https://pharmaphorum.com/news/sanofi-snaps-up-acne-vaccine-developer-origimm-bio/

News/ News/ R&D

Sanofi and Translate Bio expand mRNA vaccine agreement

Richard Staines COVID-19, infectious diseases, R&D, Sanofi-Pasteur, Translate Bio, vaccine 0 Comment

Sanofi’s Pasteur vaccines unit and Translate Bio have expanded a collaboration to develop mRNA-based vaccines across all infectious

Sanofi and Translate Bio expand mRNA vaccine agreement

https://pharmaphorum.com/news/sanofi-and-translate-bio-expand-mrna-vaccine-agreement/

News/ News/ News/ News/ Oncology/ R&D/ Sales and Marketing

David Loew swaps Sanofi’s top vaccine job for CEO role at Ipsen

Phil Taylor appointment, Ipsen, Sanofi-Pasteur, senior management 0 Comment

Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as

David Loew swaps Sanofi’s top vaccine job for CEO role at Ipsen

https://pharmaphorum.com/news/david-loew-swaps-sanofis-top-vaccine-job-for-ceo-role-at-ipsen/

News/ News/ R&D

Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio

Richard Staines coronavirus, COVID-19, R&D, Sanofi-Pasteur, Translate Bio, vaccine 0 Comment

Sanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop

Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio

https://pharmaphorum.com/news/sanofi-inks-covid-19-mrna-vaccine-deal-with-translate-bio/

Healthcare/ News

Sanofi invests in new Canadian vaccine manufacturing plant

Richard Staines manufacturing, Sanofi, Sanofi-Pasteur, vaccines 0 Comment

Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.

Sanofi invests in new Canadian vaccine manufacturing plant

https://pharmaphorum.com/news/sanofi-invests-new-canadian-vaccine-manufacturing-plant/

News/ R&D

Regeneron ends development of RSV antibody

Richard Staines AstraZeneca, infectious diseases, R&D, Regeneron, respiratory syncytial virus, Sanofi-Pasteur 0 Comment

Regeneron dumps suptavumab after phase 3 trial failure.

Regeneron ends development of RSV antibody

https://pharmaphorum.com/news/regeneron-ends-development-of-rsv-antibody/

News

Sanofi beats expectations, driven by rare diseases and vaccines

Richard Staines Dupixent, Genzyme, Lantus, Sanofi, Sanofi-Pasteur 0 Comment

But sales of key insulin fall amid biosimilar competition.

Sanofi beats expectations, driven by rare diseases and vaccines

https://pharmaphorum.com/news/sanofi-beats-expectations-driven-rare-diseases-vaccines/

News/ US

Sanofi to repay US government $19.8 million

Richard Staines pricing, reimbursement, Sanofi, Sanofi-Pasteur 0 Comment

Costly accounting error for Sanofi.

Sanofi to repay US government $19.8 million

https://pharmaphorum.com/news/sanofi-repay-us-government-19-8-million/

Trending

Sanofi-Pasteur

Login